​

BioLife Solutions (BLFS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BLFS Stock Forecast

BioLife Solutions (BLFS) stock forecast, based on 17 Wall Street analysts, predicts a 12-month average price target of $33.00, with a high of $34.00 and a low of $32.00. This represents a 76.75% increase from the last price of $18.67.

$15 $19 $23 $27 $31 $35 High: $34 Avg: $33 Low: $32 Last Closed Price: $18.67

BLFS Stock Rating

BioLife Solutions stock's rating consensus is Buy, based on 17 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 17 0 17 Strong Sell Sell Hold Buy Strong Buy

BLFS Price Target Upside V Benchmarks

TypeNameUpside
StockBioLife Solutions76.75%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks22.27%

Price Target Trends

1M3M12M
# Anlaysts-12
Avg Price Target-$34.00$33.00
Last Closing Price$18.67$18.67$18.67
Upside/Downside-82.11%76.75%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2619---10
Feb, 2619---10
Jan, 2619---10
Dec, 2519---10
Nov, 2528---10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 05, 2026Northland Securities$34.00$25.1435.24%82.11%
Nov 24, 2025Yi ChenH.C. Wainwright$32.00$26.5320.62%71.40%
Mar 05, 2025H.C. Wainwright$30.00$26.2514.29%60.69%
Nov 15, 2024Jacob JohnsonStephens$30.00$21.5839.02%60.69%
Aug 12, 2024Matt HewittCraig-Hallum$30.00$25.2518.81%60.69%
Apr 04, 2024Matthew StantonJefferies$22.00$17.3227.02%17.84%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 29, 2025H.C. WainwrightBuyBuyhold
Nov 24, 2025H.C. WainwrightBuyBuyhold
Aug 08, 2025H.C. WainwrightBuyBuyhold
Mar 05, 2025H.C. WainwrightBuyBuyhold
Nov 15, 2024StephensOverweightOverweighthold
Nov 13, 2024Cowen & Co.BuyBuyhold
Sep 30, 2024H.C. WainwrightBuyinitialise
Aug 12, 2024Craig-HallumBuyBuyhold
Jul 17, 2024Cowen & Co.BuyBuyhold
May 13, 2024BenchmarkBuyupgrade

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.23$-3.29$-1.52$-0.44$-0.25---
Avg Forecast$-0.01$-2.25$-1.57$-0.45$-0.17$0.08$0.54$0.99
High Forecast$-0.01$-1.91$-1.48$-0.42$0.09$1.09$0.58$1.06
Low Forecast$-0.01$-2.47$-1.67$-0.48$-0.55$-0.94$0.51$0.94
Surprise %2200.00%46.22%-3.18%-2.22%47.06%---

Revenue Forecast

$50M $80M $110M $140M $170M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$119.16M$76.24M$75.86M$82.25M$96.21M---
Avg Forecast$117.66M$160.90M$143.94M$104.47M$96.10M$115.50M$141.14M$170.57M
High Forecast$122.64M$172.93M$151.68M$112.97M$101.95M$117.02M$148.74M$179.75M
Low Forecast$114.03M$142.16M$138.21M$80.76M$92.15M$113.97M$135.53M$163.78M
Surprise %1.27%-52.62%-47.30%-21.27%0.12%---

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-8.91M$-139.81M$-66.43M$-20.18M$-12.13M---
Avg Forecast$18.28M$19.99M$-66.43M$-19.67M$-9.17M$622.50K$23.82M$43.28M
High Forecast$28.18M$33.03M$-33.67M$-18.36M$4.09M$47.74M$25.26M$46.31M
Low Forecast$8.38M$6.94M$-99.19M$-20.99M$-23.96M$-40.92M$22.39M$41.04M
Surprise %-148.73%-799.42%-2.59%32.23%---

BLFS Forecast FAQ

Is BioLife Solutions stock a buy?

BioLife Solutions stock has a consensus rating of Buy, based on 17 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that BioLife Solutions is a favorable investment for most analysts.

What is BioLife Solutions's price target?

BioLife Solutions's price target, set by 17 Wall Street analysts, averages $33 over the next 12 months. The price target range spans from $32 at the low end to $34 at the high end, suggesting a potential 76.75% change from the previous closing price of $18.67.

How does BioLife Solutions stock forecast compare to its benchmarks?

BioLife Solutions's stock forecast shows a 76.75% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (22.27%).

What is the breakdown of analyst ratings for BioLife Solutions over the past three months?

  • March 2026: 10.00% Strong Buy, 90.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 10.00% Strong Buy, 90.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 10.00% Strong Buy, 90.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is BioLife Solutions’s EPS forecast?

BioLife Solutions's average annual EPS forecast for its fiscal year ending in December 2026 is $0.08, marking a -132.00% decrease from the reported $-0.25 in 2025. Estimates for the following years are $0.54 in 2027, and $0.99 in 2028.

What is BioLife Solutions’s revenue forecast?

BioLife Solutions's average annual revenue forecast for its fiscal year ending in December 2026 is $115.5M, reflecting a 20.04% increase from the reported $96.21M in 2025. The forecast for 2027 is $141.14M, and $170.57M for 2028.

What is BioLife Solutions’s net income forecast?

BioLife Solutions's net income forecast for the fiscal year ending in December 2026 stands at $622.5K, representing a -105.13% decrease from the reported $-12.13M in 2025. Projections indicate $23.82M in 2027, and $43.28M in 2028.